Malignant neoplasm of connective and soft tissue, unspecified
- C49.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Malignant neoplasm of connective and soft tissue, unsp
- The 2024 edition of ICD-10-CM C49.9 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C49.9 – other international versions of ICD-10 C49.9 may differ.
The following code(s) above C49.9 contain annotation back-references
that may be applicable to C49.9:
Approximate Synonyms
- Angiosarcoma
- Atypical fibroxanthoma of skin
- Atypical fibroxanthoma, skin
- Cancer of the soft tissue
- Cancer of the synovium, sarcoma
- Cancer, angiosarcoma
- Cancer, leiomyosarcoma
- Cancer, liposarcoma
- Cancer, malignant fibrous histiocytoma
- Cancer, myxoid liposarcoma
- Cancer, rhabdomyosarcoma
- Cancer, sarcoma
- Ganglioneuroblastoma
- Leiomyosarcoma
- Liposarcoma
- Malignant fibrous histiocytoma
- Malignant neoplasm of soft tissue
- Myxoid liposarcoma
- Rhabdomyosarcoma
- Sarcoma
- Sarcoma of soft tissue
- Sarcoma, soft tissue
- Synovial sarcoma
ICD-10-CM C49.9 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 542 Pathological fractures and musculoskeletal and connective tissue malignancy with mcc
- 543 Pathological fractures and musculoskeletal and connective tissue malignancy with cc
- 544 Pathological fractures and musculoskeletal and connective tissue malignancy without cc/mcc
Convert C49.9 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change